Wtd. shares, diluted
Flow – sum over the period · M shares
Q4 2025
181.2M shares
All values (13)
| Period | Value (M shares) | Status |
|---|---|---|
| Q2 2026 | 183.3 | reported |
| Q1 2026 | 181.2 | reported |
| Q4 2025 | 181.2 | reported |
| Q3 2025 | 180.6 | reported |
| Q2 2025 | 178.1 | reported |
| Q1 2025 | 178.1 | reported |
| Q4 2024 | 177.6 | reported |
| Q3 2024 | 156.8 | reported |
| Q2 2024 | 155.2 | reported |
| Q1 2024 | 52.5 | reported |
| Q3 2023 | 37.5 | reported |
| Q2 2023 | 36.6 | reported |
| Q1 2023 | 35.8 | reported |
29 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: shares_diluted
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- 181.2M shares
- Period
- Q4 2025, ended Dec 31, 2025 · quarterly value (3 months, not cumulative)
- Source
- 8-K Ex.99, filed Feb 10, 2026 · 0001736297-26-000005
- Location
- GuV-table, column 3 months Q4. Quote: Weighted-average shares used in calculating net income (loss) per share attributable to common stockholders: Basic 169,505 167,436 159,895 166,408 131,262 Diluted 181,181 180,631 177,559 179,551 131.2
- Quote
- “Weighted-average shares used in calculating net income (loss) per share attributable to common stockholders: Basic 169,505 167,436 159,895 166,408 131,262 Diluted 181,181 180,631 177,559 179,551 131.2”
- Confidence
- 0.9 – extracted from text/tables in 8-K Ex.99, 10-K or prospectus (S-1/424B4, not XBRL-tagged), source location stored
Versions
| v1 | 181.2M shares | Feb 10, 2026 | 8-K Ex.99 0001736297-26-000005 | reported · confidence 0.9 · current |